SLC22A11 | Solute carrier family 22 (organic anion/urate transporter), member 11 | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
NAA11 | N(alpha)-acetyltransferase 11, NatA catalytic subunit | Enzymes
| | | | | Group enriched |
CLDN19 | Claudin 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
DSCR8 | Down syndrome critical region gene 8 | | | | | | Group enriched |
DUSP9 | Dual specificity phosphatase 9 | Enzymes
| | | | | Group enriched |
MAGEA11 | Melanoma antigen family A, 11 | | | | | | Group enriched |
TRIML2 | Tripartite motif family-like 2 | | | | | | Group enriched |
SLC52A1 | Solute carrier family 52 (riboflavin transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CXorf67 | Chromosome X open reading frame 67 | | | | | | Group enriched |
TRIM60 | Tripartite motif containing 60 | | | | | | Group enriched |
DLK1 | Delta-like 1 homolog (Drosophila) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PAEP | Progestagen-associated endometrial protein | Predicted secreted proteins
| | | | | Group enriched |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | | | | | | Group enriched |
PROK1 | Prokineticin 1 | Predicted secreted proteins
| | | | | Group enriched |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | | | | Group enriched |
MMP11 | Matrix metallopeptidase 11 (stromelysin 3) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Group enriched |
PRL | Prolactin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
RTL1 | Retrotransposon-like 1 | Predicted membrane proteins
| | | | | Group enriched |
SPP1 | Secreted phosphoprotein 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
HOXA13 | Homeobox A13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
LIPG | Lipase, endothelial | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
PHOSPHO1 | Phosphatase, orphan 1 | Enzymes
| | | | | Group enriched |
SLC6A2 | Solute carrier family 6 (neurotransmitter transporter), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
AADACL3 | Arylacetamide deacetylase-like 3 | | | | | | Group enriched |
ARMS2 | Age-related maculopathy susceptibility 2 | Disease related genes Mitochondrial proteins
| | | | | Group enriched |
CHRM5 | Cholinergic receptor, muscarinic 5 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | | | | Group enriched |
OLAH | Oleoyl-ACP hydrolase | Enzymes
| | | | | Group enriched |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
ELOVL2 | ELOVL fatty acid elongase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
GDPD4 | Glycerophosphodiester phosphodiesterase domain containing 4 | Predicted membrane proteins
| | | | | Group enriched |
GPR78 | G protein-coupled receptor 78 | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
IDO2 | Indoleamine 2,3-dioxygenase 2 | | | | | | Group enriched |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | | | | Group enriched |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CTSV | Cathepsin V | Enzymes Predicted secreted proteins
| | | | | Group enriched |
DLX5 | Distal-less homeobox 5 | Disease related genes Transcription factors
| | | | | Group enriched |
DLX6 | Distal-less homeobox 6 | Transcription factors
| | | | | Group enriched |
GABRA4 | Gamma-aminobutyric acid (GABA) A receptor, alpha 4 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT23 | Keratin 23 (histone deacetylase inducible) | | | | | | Group enriched |
SERPINB2 | Serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SLC30A2 | Solute carrier family 30 (zinc transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SVEP1 | Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | Predicted secreted proteins
| | | | | Group enriched |
TBX5 | T-box 5 | Disease related genes Transcription factors
| | | | | Group enriched |